ONCOtracker Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ONCOtracker's estimated annual revenue is currently $930k per year.(i)
  • ONCOtracker's estimated revenue per employee is $155,000

Employee Data

  • ONCOtracker has 6 Employees.(i)
  • ONCOtracker grew their employee count by 0% last year.

ONCOtracker's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is ONCOtracker?

Founded by myeloma research pioneer and oncologist, James R. Berenson, M.D., OncoTracker provides proprietary serum BCMA testing, patient-derived xenografts (PDX), access to an ongoing extensive library of clinically characterized biospecimens, and consultative services, to help pharmaceutical and biotechnology companies develop and evaluate new drugs. OncoTracker’s facilities, including a state-of-the-art GLP laboratory and biorepository, are ideally suited to support drug development and clinical studies worldwide. Located in West Hollywood, CA, the company has provided critical testing, biospecimens, patient-derived xenografts and consultative guidance to research institutions, pharmaceutical companies and contract research organizations around the world to further the development of BCMA-directed drugs. OncoTracker welcomes the opportunity to discuss how its unique testing services and programs may help your drug development needs.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M6-14%N/A
#2
$0.4M6-14%N/A
#3
$3.5M7-30%N/A
#4
$0.5M70%N/A
#5
$0.5M70%N/A